Advertisement

Topics

Latest Top Pharmaceutical Companies in South Korea NewsRSS

09:39 EDT 30th September 2016 | BioPortfolio

Boehringer Ingelheim Ends Partnership With Hanmi to Develop Lung Cancer Candidate

Boehringer Ingelheim will return development and global commercialization rights to Hanmi Pharmaceutical’s lung cancer candidate olmutinib, the companies said today, ending a year-long collaboration that could have generated up to $730 million for the South Korean drug developer. Olmutinib—also known as HM61713 and BI 1482694—is a third generation epidermal growth factor rece...

Genentech commits $80M upfront in Hanmi licensing deal

The Roche subsidiary will have sole rights to commercialize Hanmi’s tumor-suppressing drug outside of South Korea.

Genentech to Develop Hanmi Cancer Candidate HM95573

Genentech, a member of the Roche Group, will develop and commercialize Hanmi Pharmaceutical’s Phase I cancer candidate HM95573 in most of the world, through a license agreement that could generate up to $910 million for the South Korean drug developer. The exclusive development and license agreement gives Genentech worldwide rights, except in South Korea, to HM95573, a selective pan-rapi...

Researchers reveal how dangerous intestinal toxin enters cells

BOSTON, Sept. 28, 2016 /PRNewswire-USNewswire/ -- Researchers have identified a key target in fighting the emerging, life-threatening gastrointestinal infection Clostridium difficile. The work, led by Min Dong, PhD, and Liang Tao, PhD, of Boston Children's Hospital, reveals how the bug's most potent toxin gets into cells, the first step in developing treatments against it. Findings are published t...

Dong E E Jiao to Take Part in 2016 International Conference on Health Preservation

BEIJING, Sept. 20, 2016 /PRNewswire/ -- A press conference for the 2016 International Conference on Health Preservation was held at the Great Hall of the People in Beijing on September 18, 2016. The year's event had the distinction of having an exclusive invited guest who spoke on the use of tonics and on wellness at the conference, Qin Yufeng, President of Dong E E Jiao Co...

Women with NAFLD, especially users of HT, more susceptible to severe liver tissue injury

Women with nonalcoholic fatty liver disease who are premenopausal or those using synthetic hormones — birth control or hormone replacement therapy — show more severe hepatic injury and inflammation than their male counterparts, according to research published in Clinical Gastroenterology and Hepatology.“We investigated the relationships of [nonalcoholic steatohepatitis] histologic severity t...

Diazyme Prevails in Maintaining Its Right to Distribute Its Procalcitonin (PCT) Test in Germany

SAN DIEGO, CA--(Marketwired - September 09, 2016) - Diazyme Laboratories announces that it will continue to distribute its procalcitonin (PCT) test in Germany through its German subsidiary Diazyme Europe. This follows the lifting by the district court of Munich on August 31, 2016 of a preliminary injunction obtained by B.R.A.H.M.S. GmbH (BRAHMS) on July 13, 2016 based on alleged infringement of B...

Diazyme Is Excited to Now Offer the Diadexus PLAC(R) Assays

SAN DIEGO, CA--(Marketwired - August 01, 2016) - Diazyme Laboratories today announced that it has purchased substantially all of the assets of Diadexus, Inc. (Diadexus), including all intellectual property. Diazyme is excited to now offer the Diadexus PLAC® assays. "Adding the PLAC assays to Diazyme's already comprehensive diagnostic testing for heart disease demonstrates Diazyme's commitment to...

Stem cells could be used to heal heart attack damage

SOURCE   July 2016 Doctor James Chong has won a major prize for his work, which uses stem cells to help reverse the effects of heart failure. A Sydney researcher has discovered stem cells could be the key to reversing the effects of heart attacks. Dr James Chong was today […]

Multiple Sclerosis Pipeline Review Report of 178 Companies

PUNE, India, July 14, 2016 /PRNewswire/ -- ReportsnReports.com adds "Multiple Sclerosis - Pipeline Review, H1 2016" market research report to its store providing an overview of the Multiple Sclerosis's therapeutic pipeline complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along ...

Korean Gov’t cautiously approves stem cell research

   SOURCE July 12,2016 The health authority gave approval Monday to a private university to carry out a project in embryonic stem cells, resuming controversial research that has been shut down for seven years. Professor Lee Dong-ryul of CHA University in Pocheon, Gyeonggi, 30 miles northeast of Seoul, will lead […]

South Korea’s biotech scene grows up with new venture capital launch

South Korea's fledgling biotech industry is taking a step forward as Hanmi Pharmaceuticals launches a venture capital arm.

Hanmi Selects Medidata to Power Drug Development with Cloud Technology

Korea’s Top Pharma Adopts Medidata’s Platform to Optimize All Clinical Trials Across Therapeutic Areas NEW YORK–(BUSINESS WIRE)–#Hanmi—Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research, announced today that it has signed a multi-year enterprise deal with Hanmi Pharmaceutical, one of South … Con...

Frost & Sullivan Honors South Korea's Best Companies at the 2016 South Korea Excellence Awards

SEOUL, South Korea, June 28, 2016 /PRNewswire/ -- Frost & Sullivan today honored and recognized South Korea's best companies at the 2016 South Korea Excellence Awards banquet. AhnLab received the Industrial Control Systems Security Technology Innovation award while ECS Telecom was honored with the Unified Communications System Integrator of the Year. Mr. Hee Sang Koo, Country Head of Frost ...

Evergreen, Licensor of Tommy Chong's Marijuana Brand "Chong's Choice" and Segra Form Strategic Alliance That Delivers High Technology Precision to the $25 Billion Cannabis Industry

LOS ANGELES, CA -- (Marketwired) -- 06/27/16 -- Segra Biogen Corp., a Cannabis Science Company, and Evergreen Licensing, LLC, a California Corporation and the licensor of Tommy Chong's brand "Chong's Choice," have announced plans for Segra to become the science advisor for the Chong's Choice brand. Segra will advise Chong's Choice on matters of industrial scale Cannabis tissue culture and geneti...

Pulmonary Fibrosis - Pipeline Review, H1 2016

Recently added to the BioPortfolio report store, Pulmonary Fibrosis - Pipeline Review, H1 2016 is a new report from GlobalData published on 2016-04-12. This 380-page report is available in PDF from $2000. Pulmonary Fibrosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Fibrosis pipeline lan...

Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016

Recently added to the BioPortfolio report store, Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016 is a new report from published on 2016-04-26. This 258-page report is available in PDF from $2000. Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Idiopath...

Ulcerative Colitis - Pipeline Review, H1 2016

Recently added to the BioPortfolio report store, Ulcerative Colitis - Pipeline Review, H1 2016 is a new report from published on 2016-04-26. This 260-page report is available in PDF from $2000. Ulcerative Colitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2016’, provides an overview of the Ulcerative Colitis pipeline landscape. T...

Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016

Recently added to the BioPortfolio report store, Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016 is a new report from published on 2016-04-29. This 49-page report is available in PDF from $3500. Cholesteryl Ester Transfer Protein (Lipid Transfer Protein I or CETP) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cholesteryl Ester ...

Vitaeris Announces Seed Financing and Appointment of Executive Team

US$7 Million Financing and Experienced Executive Team to EnableClinical Advancement of Clazakizumab VANCOUVER, June 6, 2016 /PRNewswire/ - Vitaeris Inc., a clinical-stage biopharmaceutical company focused on innovative applications in chronic inflammatory diseases, today announced it has closed a US$7 million seed round financing, including participation by key founding investor HBM Healthcare ...

Type 2 Diabetes Market Pipeline Covering 221 Companies for H1 2016 Reviewed in New Research Report

PUNE, India, June 1, 2016 /PRNewswire/ -- The "Type 2 Diabetes - Pipeline Review, H1 2016" is a professional and in-depth market research report providing an overview of therapeutic pipeline for Type 2 diabetes complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...

Ulcerative Colitis Market 2016 Pipeline Review of 108 Companies

PUNE, India, May 30, 2016 /PRNewswire/ -- LifeScienceIndustryResearch.com adds "Ulcerative Colitis - Pipeline Review, H1 2016" market research report with comprehensive information on the therapeutic development for Ulcerative Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...

Ongoing Corporate Takeover at Sorrento Therapeutics (SRNE)

On Thursday, June 30, 2016, Sorrento Therapeutics (SRNE) will be holding its annual meeting of stockholders. It will be held at Noon (PDT) at Cooley LLP: 4401 Eastgate Mall, San Diego, CA 92121.

Collaboration improves HBV screening, linkage-to-care for Asians

Researchers from UC Davis Comprehensive Cancer Center engaged organizations in Sacramento County, California to link Asian populations to hepatitis B virus infection care. They found that more screening led to more linkage-to-care, in turn preventing spread of infection and liver disease, according to research published in Public Health Reports.Julie Dang, MPH, director of community engagement and...

Neovacs to attend ChinaBio® Event May 18 & 19, 2016

  PRESS RELEASE· PRESS RELEASE· PRESS RELEASE Neovacs to attend ChinaBio® EventMay 18 & 19, 2016 Paris and Boston, May 17th, 2016 - Neovacs (Alternext Paris: ALNEV) a leader in active immunotherapy for the treatment of

Quick Search
Advertisement
 

review and buy Top Pharmaceutical Companies in South Korea market research data and corporate reports here